A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors Vicente-Duenas, Carolina; Romero-Camarero, Isabel; Gonzalez-Herrero, Ines; Alonso-Escudero, Esther; Abollo-Jimenez, Fernando; Jiang, Xiaoyu; Gutierrez, Norma C.; Orfao, Alberto; Marin, Nieves; Maria Villar, Luisa; Fernandez Criado, Ma Carmen; Pintado, Belen; Flores, Teresa; De Las Rivas, Javier; Jimenez, Rafael; Garcia Criado, Francisco Javier; Garcia Cenador, Maria Begona; Lossos, Izidore S.; Cobaleda, Cesar; Sanchez-Garcia, Isidro. Embo Journal. , 31: 3704-3717. FI: 9,205 (Q1) (D1) Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels Crespo, Ines; Tao, Herminio; Belen Nieto, Ana; Rebelo, Olinda; Domingues, Patricia; Vital, Ana Luisa; del Carmen Patino, Maria; Barbosa, Marcos; Lopes, Maria Celeste; Oliveira, Catarina Resende; Orfao, Alberto; Dolores Tabernero, Maria. Plos One. , 7. FI: 4,092 (Q1) (D2) An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis. Teodosio, C.; Garcia-Montero, A. C.; Jara-Acevedo, M.; Alvarez-Twose, I.; Sanchez-Munoz, L.; Almeida, J.; Morgado, J. M.; Matito, A.; Escribano, L.; Orfao, A.. Leukemia. , 26: 951-958. FI: 9,561 (Q1) (D1) Association of myelodysplastic syndrome with CD5+, CD23+ monoclonal B-cell lymphocytosis Sandes AF; Chauffaille Mde L; Orfao A; Siufi GC; Silva MR; Yamamoto M. Clinics. , 67: 1487-1491. FI: 2,058 (Q2) (D3) Biomarker Discovery by Novel Sensors Based on Nanoproteomics Approaches Dasilva N; Díez P; Matarraz S; González-González M; Paradinas S; Orfao A; Fuentes M. Sensors. , 12: 2284-2308. FI: 1,739 (Q1) (D3) Bone marrow transplantation extends its scope Sánchez-Guijo FM; Orfao A; Del Cañizo MC. Advances In Experimental Medicine And Biology. , 741: 121-134. FI: 1,093 (Q3) (D7) CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype Paíno T; Ocio EM; Paiva B; San-Segundo L; Garayoa M; Gutiérrez NC; Sarasquete ME; Pandiella A; Orfao A; San Miguel JF. Haematologica-The Hematology Journal. , 97: 1110-1114. FI: 6,424 (Q1) Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients Paiva, B.; Gutierrez, N-C; Chen, X.; Vidriales, M-B; Montalban, M-A; Rosinol, L.; Oriol, A.; Martinez-Lopez, J.; Mateos, M-V; Lopez-Corral, L.; Diaz-Rodriguez, E.; Perez, J-J; Fernandez-Redondo, E.; de Arriba, F.; Palomera, L.; Bengoechea, E.; Terol, M-J; de Paz, R.; Martin, A.; Hernandez, J.; Orfao, A.; Lahuerta, J-J; Blade, J.; Pandiella, A.; San Miguel, J-F; GEM Cooperative Study Grp; PETHEMA Cooperative Study Grp. Leukemia , 26: 1862-1869. FI: 9,561 (Q1) (D1) Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults Casabonne D; Almeida J; Nieto WG; Romero A; Fernández-Navarro P; Rodriguez-Caballero A; Muñoz-Criado S; Díaz MG; Benavente Y; de Sanjosé S; Orfao A. Plos One. 7. FI: 4,092 (Q1) (D2) Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays Tabernero MD; Maíllo A; Nieto AB; Diez-Tascón C; Lara M; Sousa P; Otero A; Castrillo A; Patino-Alonso Mdel C; Espinosa A; Mackintosh C; de Alava E; Orfao A. Genes Chromosomes & Cancer , 51: 606-617. FI: 3,306 (Q2) (D4)
|
